All dMMR cases, excluding those with BRAF-V600E mutation or MLH1 promoter methylation (rarely reported in LS-related tumors), should be tested for germline mutations in MMR genes to confirm their LS diagnosis [14,15,20,32,37,38]. This evidence concerns the gene MRC1 and Leigh syndrome.